Alpha Tau Medical Ltd

NASDAQ DRTS

Data sourced from

and

Download Data

Alpha Tau Medical Ltd Net Income for the quarter ending March 31, 2024: USD -7.98 M

Alpha Tau Medical Ltd Net Income is USD -7.98 M for the quarter ending March 31, 2024, a -97,383.82% change year over year. Net Income is the profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Alpha Tau Medical Ltd Net Income for the quarter ending March 31, 2023 was USD -8.19 K, a 99.97% change year over year.
Alpha Tau Medical Ltd Net Income for the quarter ending March 31, 2022 was USD -25.74 M, a -119.83% change year over year.
Alpha Tau Medical Ltd Net Income for the quarter ending March 31, 2021 was USD -11.71 M, a -427.40% change year over year.
Alpha Tau Medical Ltd Net Income for the quarter ending March 31, 2020 was USD -2.22 M, a -4.94% change year over year.

NASDAQ: DRTS

Alpha Tau Medical Ltd

CEO	Mr. Uzi Sofer
IPO Date	March 8, 2021
Location	Israel
Headquarters	5 Kiryat Hamada Street, Jerusalem, Israel, 9777605
Employees	121
Sector	Healthcare
Industry	Biotechnology

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Key trends